Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Outgoing Frontier Developments chairman lowers stake

(Sharecast News) - Frontier Developments revealed on Monday that outgoing chairman David Gammon had disposed of 35,000 ordinary shares in the AIM-listed video games developer.

Gammon, who took over as chairman in 2012, sold the shares on Friday at an average price of 1,400.0p each, for a total value of £490,000.

Gammon remains beneficially interested in a total of 245,000 ordinary Frontier shares, representing 0.6% of the company's issued share capital.

As of 1625 GMT, Frontier Developments shares were up 1.14% at 1,414.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Seeing Machines Ltd. Npv (di) (SEE) Director name: Brown,Michael Amount purchased: 134,208,640 @ 5.50p Value: £7,381,475.16

K3 Business Technology Group (KBT) Director name: Scott,Oliver Rupert Andrew Amount purchased: 200,000 @ 90.00p Value: £180,000.00

Wizz Air Holdings (WIZZ) Director name: Andsager,Charlotte Amount purchased: 4,000 @ 2,277.00p Value: £91,080.00

Time Finance (TIME) Director name: Russell,Ronald Amount purchased: 344,821 @ 17.40p Value: £59,998.85

K3 Business Technology Group (KBT) Director name: Scott,Oliver Rupert Andrew Amount purchased: 30,003 @ 115.10p Value: £34,533.42

Oxford Biodynamics (OBD) Director name: Diggle,Stephen Charles Amount purchased: 112,051 @ 18.20p Value: £20,393.28

Chesnara (CSN) Director name: Hesketh,Mark Amount purchased: 6,000 @ 277.39p Value: £16,643.40

Chesnara (CSN) Director name: Hesketh,Mark Amount purchased: 4,000 @ 272.00p Value: £10,880.00

Strip Tinning Holdings (STG) Director name: Barton,Richard Amount purchased: 13,725 @ 72.50p Value: £9,950.63

Oxford Biodynamics (OBD) Director name: Diggle,Stephen Charles Amount purchased: 50,000 @ 18.00p Value: £9,000.00

Barratt Developments (BDEV) Director name: Scott,Mike Amount purchased: 992 @ 412.00p Value: £4,087.04

Schroder Income Growth Fund (SCF) Director name: McIntyre ,Fraser Amount purchased: 149 @ 289.22p Value: £430.94

Firstgroup (FGP) Director name: Mangold,Ryan Amount purchased: 164 @ 91.66p Value: £150.32

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 820 @ 18.30p Value: £150.06

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 820 @ 18.30p Value: £150.06

Zotefoams (ZTF) Director name: McGrath ,Gary Amount purchased: 45 @ 333.00p Value: £149.85

Zotefoams (ZTF) Director name: Stirling,David Amount purchased: 45 @ 333.00p Value: £149.85

Mitchells & Butlers (MAB) Director name: Jones,Timothy (Tim) Charles Amount purchased: 93 @ 148.81p Value: £138.39

Mitchells & Butlers (MAB) Director name: Urban,Phil Amount purchased: 92 @ 148.81p Value: £136.91

Top Director Sells

Seeing Machines Ltd. Npv (di) (SEE) Director name: Brown,Michael Amount sold: 207,208,640 @ 5.50p Value: £11,396,475.14

Frontier Developments (FDEV) Director name: Gammon,David Ranken Amount sold: 35,000 @ 1,400.00p Value: £490,000.00

Share this article

Related Sharecast Articles

Director dealings: Essentra CEO raises stake
(Sharecast News) - Essentra revealed on Wednesday that chief execuitve Scott Fawcett had acquired 17,483 ordinary shares in the FTSE 250-listed hardware manufacturer.
Director dealings: AB Dynamics CEO snaps up shares
(Sharecast News) - AB Dynamics revealed on Tuesday that chief executive Sarah Matthews-DeMers had acquired 2,000 ordinar shares in the AIM-listed automotive testing and development solution supplier.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.